Tumor-infiltrating lymphocytes (TILs) and CD8+ T cells are unable to efficiently perform effector functions and thus eliminate cancer cells due to various immunosuppressive mechanisms present in the tumor microenvironment (TME) [15]. The gene discussed is CD8A; the disease is neoplasm.